Articles with "fezf1 as1" as a keyword



Photo by dylan_nolte from unsplash

LncRNA FEZF1-AS1 accelerates multiple myeloma progression by regulating IGF2BP1/BZW2 signaling.

Sign Up to like & get
recommendations!
Published in 2023 at "Hematological oncology"

DOI: 10.1002/hon.3157

Abstract: Multiple myeloma (MM) is the second largest hematological tumor with clonal proliferation of malignant plasma cells. Growing reports have revealed that the dysregulation of long non-coding RNA (lncRNA) is involved in the MM progression. Nevertheless,… read more here.

Keywords: multiple myeloma; lncrna fezf1; bzw2; fezf1 as1 ... See more keywords
Photo by ospanali from unsplash

FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma

Sign Up to like & get
recommendations!
Published in 2019 at "Bioscience Reports"

DOI: 10.1042/bsr20190754

Abstract: Long non-coding RNA (lncRNA) FEZF1 antisense RNA 1 (FEZF1-AS1) has been shown to be up-regulated in tumor tissues and cells, and exerts oncogenic effects on various types of malignancies. However, the expression and function of… read more here.

Keywords: retinoblastoma patients; as1 expression; fezf1 as1; retinoblastoma ... See more keywords
Photo by paipai90 from unsplash

FEZF1-AS1: a novel vital oncogenic lncRNA in multiple human malignancies

Sign Up to like & get
recommendations!
Published in 2019 at "Bioscience Reports"

DOI: 10.1042/bsr20191202

Abstract: Long noncoding RNAs (LncRNAs) refer to the RNA with a length of >200 nucleotides, which lack or have no open reading coding frame and have higher tissue and organ specificity compared with the protein coding… read more here.

Keywords: human malignancies; oncogenic lncrna; vital oncogenic; novel vital ... See more keywords
Photo by ospanali from unsplash

Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors

Sign Up to like & get
recommendations!
Published in 2019 at "Medicine"

DOI: 10.1097/md.0000000000015982

Abstract: Abstract Background: FEZ family zinc finger 1 antisense RNA 1 (FEZF1-AS1), as a novel lncRNA, was reported to be up-regulated in various cancers and involved in tumor progression. This study systematically assessed the prognostic value… read more here.

Keywords: expression; prognostic value; fezf1 as1; solid tumors ... See more keywords
Photo by nci from unsplash

LncRNA–FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling

Sign Up to like & get
recommendations!
Published in 2018 at "Clinical Cancer Research"

DOI: 10.1158/1078-0432.ccr-17-2967

Abstract: Purpose: Long non-coding RNAs (lncRNAs) play key roles in human cancers. Here, FEZF1-AS1, a highly overexpressed lncRNA in colorectal cancer, was identified by lncRNA microarrays. We aimed to explore the roles and possible molecular mechanisms… read more here.

Keywords: pkm2; colorectal cancer; fezf1 as1; as1 promotes ... See more keywords
Photo by paramir from unsplash

Long noncoding RNA FEZF1-AS1 promotes the motility of esophageal squamous cell carcinoma through Wnt/β-catenin pathway

Sign Up to like & get
recommendations!
Published in 2019 at "Cancer Management and Research"

DOI: 10.2147/cmar.s196004

Abstract: Background: Long noncoding RNAs (lncRNAs), a class of noncoding RNA nucleotides >200 bp, has been demonstrated to play vital role in the development of cancer. FEZ family zinc finger 1 antisense RNA 1 (FEZF1-AS1) has… read more here.

Keywords: fezf1 as1; long noncoding; escc; fezf1 ... See more keywords
Photo by nci from unsplash

Long non-coding RNA FEZF1-AS1 promotes rectal cancer progression by competitively binding miR-632 with FAM83A

Sign Up to like & get
recommendations!
Published in 2022 at "Acta Biochimica et Biophysica Sinica"

DOI: 10.3724/abbs.2022022

Abstract: The long non-coding RNA (lncRNA) forebrain embryonic zinc finger protein 1 antisense RNA1 (FEZF1-AS1) was recently identified as an oncogenic gene in several types of tumors. The biological function of FEZF1-AS1 in rectal cancer progression,… read more here.

Keywords: rectal cancer; cancer progression; fezf1 as1;